A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL

Nitin Jain, Kumudha Balakrishnan, Alessandra Ferrajoli, Susan M. O'Brien, Jan A. Burger, Tapan M. Kadia, Jorge E. Cortes, Mary L. Ayres, Francesco Paolo Tambaro, Michael J. Keating, Varsha Gandhi, William G. Wierda

Research output: Contribution to journalArticle

4 Scopus citations

Fingerprint Dive into the research topics of 'A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL'. Together they form a unique fingerprint.

Medicine & Life Sciences